NovaBay Pharmaceuticals, Inc. Debt Growth

Debt Growth of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Debt Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Debt Growth for the quarter ending June 30, 2022 was 6.49 (a 32.65% increase compared to previous quarter)
  • Year-over-year quarterly Debt Growth decreased by -1001.12%
  • Annual Debt Growth for 2021 was 0.1 (a -110.89% decrease from previous year)
  • Annual Debt Growth for 2020 was -0.88 (a -160.61% decrease from previous year)
  • Annual Debt Growth for 2019 was 1.44 (a -90.11% decrease from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Debt Growth of NovaBay Pharmaceuticals, Inc.

Most recent Debt Growthof NBY including historical data for past 10 years.

Interactive Chart of Debt Growth of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Debt Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 6.49 4.89
2021 0.1 -0.72 -0.79 -0.88 0.1
2020 -0.88 -0.58 -0.62 0.47 -0.88
2019 6.72 -0.45 1.31 53.76 1.44
2016 3.94 17.23
2015 5.11 14.61

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology